0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cosmetics Anti-inflammatory Ingredient Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-8L17372
Home | Market Reports | Beauty & Fitness| Face & Body Care| Make-Up & Cosmetics
Global Cosmetics Anti inflammatory Ingredient Market Research Report 2024
BUY CHAPTERS

Global Cosmetics Anti-inflammatory Ingredient Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-8L17372
Report
November 2025
Pages:202
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Cosmetics Anti-inflammatory Ingredient Market

The global Cosmetics Anti-inflammatory Ingredient market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Facial Care accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Cosmetics Anti-inflammatory Ingredient leading manufacturers including Lonza, Jubilant Life Sciences, Vertellus, Lasons India, DSM, BASF, Indena S.p.A., Symrise, Croda, Seppic, etc., dominate supply; the top five capture approximately % of global revenue, with Lonza leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Cosmetics Anti-inflammatory Ingredient market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Cosmetics Anti-inflammatory Ingredient Market Report

Report Metric Details
Report Name Cosmetics Anti-inflammatory Ingredient Market
Segment by Type
  • Purslane Extract
  • Centella Asiatica Extract
  • Nicotinamide
  • Allantoin
  • Peptide
  • Bisabolol
  • Resveratrol
  • Others
Segment by Application
  • Facial Care
  • Body Care
  • Hand Care
  • Foot Care
  • Others
Production by Region
  • North America
  • Europe
  • China
  • Japan
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Lonza, Jubilant Life Sciences, Vertellus, Lasons India, DSM, BASF, Indena S.p.A., Symrise, Croda, Seppic, Lipoid Kosmetik AG, Plamed Green Science Group, Durae Corporation, Dermalab, The Garden of Naturalsolution, Ashland, Akema, Clariant, Rita Corp, ExperChem, Active Peptide Company, Evolva, Sabinsa, InterHealth, Maypro, Laurus Labs
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Cosmetics Anti-inflammatory Ingredient study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
  • Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
  • Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Cosmetics Anti-inflammatory Ingredient Market report?

Ans: The main players in the Cosmetics Anti-inflammatory Ingredient Market are Lonza, Jubilant Life Sciences, Vertellus, Lasons India, DSM, BASF, Indena S.p.A., Symrise, Croda, Seppic, Lipoid Kosmetik AG, Plamed Green Science Group, Durae Corporation, Dermalab, The Garden of Naturalsolution, Ashland, Akema, Clariant, Rita Corp, ExperChem, Active Peptide Company, Evolva, Sabinsa, InterHealth, Maypro, Laurus Labs

What are the Application segmentation covered in the Cosmetics Anti-inflammatory Ingredient Market report?

Ans: The Applications covered in the Cosmetics Anti-inflammatory Ingredient Market report are Facial Care, Body Care, Hand Care, Foot Care, Others

What are the Type segmentation covered in the Cosmetics Anti-inflammatory Ingredient Market report?

Ans: The Types covered in the Cosmetics Anti-inflammatory Ingredient Market report are Purslane Extract, Centella Asiatica Extract, Nicotinamide, Allantoin, Peptide, Bisabolol, Resveratrol, Others

1 Study Coverage
1.1 Introduction to Cosmetics Anti-inflammatory Ingredient: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Cosmetics Anti-inflammatory Ingredient Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Purslane Extract
1.2.3 Centella Asiatica Extract
1.2.4 Nicotinamide
1.2.5 Allantoin
1.2.6 Peptide
1.2.7 Bisabolol
1.2.8 Resveratrol
1.2.9 Others
1.3 Market Segmentation by Application
1.3.1 Global Cosmetics Anti-inflammatory Ingredient Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Facial Care
1.3.3 Body Care
1.3.4 Hand Care
1.3.5 Foot Care
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Cosmetics Anti-inflammatory Ingredient Revenue Estimates and Forecasts 2020-2031
2.2 Global Cosmetics Anti-inflammatory Ingredient Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Cosmetics Anti-inflammatory Ingredient Sales Estimates and Forecasts 2020-2031
2.4 Global Cosmetics Anti-inflammatory Ingredient Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Cosmetics Anti-inflammatory Ingredient Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Cosmetics Anti-inflammatory Ingredient Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Cosmetics Anti-inflammatory Ingredient Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Purslane Extract Market Size by Manufacturers
4.5.2 Centella Asiatica Extract Market Size by Manufacturers
4.5.3 Nicotinamide Market Size by Manufacturers
4.5.4 Allantoin Market Size by Manufacturers
4.5.5 Peptide Market Size by Manufacturers
4.5.6 Bisabolol Market Size by Manufacturers
4.5.7 Resveratrol Market Size by Manufacturers
4.5.8 Others Market Size by Manufacturers
4.6 Global Cosmetics Anti-inflammatory Ingredient Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Cosmetics Anti-inflammatory Ingredient Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Cosmetics Anti-inflammatory Ingredient Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Cosmetics Anti-inflammatory Ingredient Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Cosmetics Anti-inflammatory Ingredient Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Cosmetics Anti-inflammatory Ingredient Sales and Revenue by Type (2020-2031)
7.4 North America Cosmetics Anti-inflammatory Ingredient Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Cosmetics Anti-inflammatory Ingredient Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Cosmetics Anti-inflammatory Ingredient Sales and Revenue by Type (2020-2031)
8.4 Europe Cosmetics Anti-inflammatory Ingredient Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Cosmetics Anti-inflammatory Ingredient Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Cosmetics Anti-inflammatory Ingredient Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Cosmetics Anti-inflammatory Ingredient Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Cosmetics Anti-inflammatory Ingredient Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Cosmetics Anti-inflammatory Ingredient Sales and Revenue by Type (2020-2031)
10.4 Central and South America Cosmetics Anti-inflammatory Ingredient Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Cosmetics Anti-inflammatory Ingredient Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Cosmetics Anti-inflammatory Ingredient Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Cosmetics Anti-inflammatory Ingredient Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Cosmetics Anti-inflammatory Ingredient Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Lonza
12.1.1 Lonza Corporation Information
12.1.2 Lonza Business Overview
12.1.3 Lonza Cosmetics Anti-inflammatory Ingredient Product Models, Descriptions and Specifications
12.1.4 Lonza Cosmetics Anti-inflammatory Ingredient Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Lonza Cosmetics Anti-inflammatory Ingredient Sales by Product in 2024
12.1.6 Lonza Cosmetics Anti-inflammatory Ingredient Sales by Application in 2024
12.1.7 Lonza Cosmetics Anti-inflammatory Ingredient Sales by Geographic Area in 2024
12.1.8 Lonza Cosmetics Anti-inflammatory Ingredient SWOT Analysis
12.1.9 Lonza Recent Developments
12.2 Jubilant Life Sciences
12.2.1 Jubilant Life Sciences Corporation Information
12.2.2 Jubilant Life Sciences Business Overview
12.2.3 Jubilant Life Sciences Cosmetics Anti-inflammatory Ingredient Product Models, Descriptions and Specifications
12.2.4 Jubilant Life Sciences Cosmetics Anti-inflammatory Ingredient Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Jubilant Life Sciences Cosmetics Anti-inflammatory Ingredient Sales by Product in 2024
12.2.6 Jubilant Life Sciences Cosmetics Anti-inflammatory Ingredient Sales by Application in 2024
12.2.7 Jubilant Life Sciences Cosmetics Anti-inflammatory Ingredient Sales by Geographic Area in 2024
12.2.8 Jubilant Life Sciences Cosmetics Anti-inflammatory Ingredient SWOT Analysis
12.2.9 Jubilant Life Sciences Recent Developments
12.3 Vertellus
12.3.1 Vertellus Corporation Information
12.3.2 Vertellus Business Overview
12.3.3 Vertellus Cosmetics Anti-inflammatory Ingredient Product Models, Descriptions and Specifications
12.3.4 Vertellus Cosmetics Anti-inflammatory Ingredient Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Vertellus Cosmetics Anti-inflammatory Ingredient Sales by Product in 2024
12.3.6 Vertellus Cosmetics Anti-inflammatory Ingredient Sales by Application in 2024
12.3.7 Vertellus Cosmetics Anti-inflammatory Ingredient Sales by Geographic Area in 2024
12.3.8 Vertellus Cosmetics Anti-inflammatory Ingredient SWOT Analysis
12.3.9 Vertellus Recent Developments
12.4 Lasons India
12.4.1 Lasons India Corporation Information
12.4.2 Lasons India Business Overview
12.4.3 Lasons India Cosmetics Anti-inflammatory Ingredient Product Models, Descriptions and Specifications
12.4.4 Lasons India Cosmetics Anti-inflammatory Ingredient Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Lasons India Cosmetics Anti-inflammatory Ingredient Sales by Product in 2024
12.4.6 Lasons India Cosmetics Anti-inflammatory Ingredient Sales by Application in 2024
12.4.7 Lasons India Cosmetics Anti-inflammatory Ingredient Sales by Geographic Area in 2024
12.4.8 Lasons India Cosmetics Anti-inflammatory Ingredient SWOT Analysis
12.4.9 Lasons India Recent Developments
12.5 DSM
12.5.1 DSM Corporation Information
12.5.2 DSM Business Overview
12.5.3 DSM Cosmetics Anti-inflammatory Ingredient Product Models, Descriptions and Specifications
12.5.4 DSM Cosmetics Anti-inflammatory Ingredient Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 DSM Cosmetics Anti-inflammatory Ingredient Sales by Product in 2024
12.5.6 DSM Cosmetics Anti-inflammatory Ingredient Sales by Application in 2024
12.5.7 DSM Cosmetics Anti-inflammatory Ingredient Sales by Geographic Area in 2024
12.5.8 DSM Cosmetics Anti-inflammatory Ingredient SWOT Analysis
12.5.9 DSM Recent Developments
12.6 BASF
12.6.1 BASF Corporation Information
12.6.2 BASF Business Overview
12.6.3 BASF Cosmetics Anti-inflammatory Ingredient Product Models, Descriptions and Specifications
12.6.4 BASF Cosmetics Anti-inflammatory Ingredient Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 BASF Recent Developments
12.7 Indena S.p.A.
12.7.1 Indena S.p.A. Corporation Information
12.7.2 Indena S.p.A. Business Overview
12.7.3 Indena S.p.A. Cosmetics Anti-inflammatory Ingredient Product Models, Descriptions and Specifications
12.7.4 Indena S.p.A. Cosmetics Anti-inflammatory Ingredient Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 Indena S.p.A. Recent Developments
12.8 Symrise
12.8.1 Symrise Corporation Information
12.8.2 Symrise Business Overview
12.8.3 Symrise Cosmetics Anti-inflammatory Ingredient Product Models, Descriptions and Specifications
12.8.4 Symrise Cosmetics Anti-inflammatory Ingredient Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 Symrise Recent Developments
12.9 Croda
12.9.1 Croda Corporation Information
12.9.2 Croda Business Overview
12.9.3 Croda Cosmetics Anti-inflammatory Ingredient Product Models, Descriptions and Specifications
12.9.4 Croda Cosmetics Anti-inflammatory Ingredient Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.9.5 Croda Recent Developments
12.10 Seppic
12.10.1 Seppic Corporation Information
12.10.2 Seppic Business Overview
12.10.3 Seppic Cosmetics Anti-inflammatory Ingredient Product Models, Descriptions and Specifications
12.10.4 Seppic Cosmetics Anti-inflammatory Ingredient Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.10.5 Seppic Recent Developments
12.11 Lipoid Kosmetik AG
12.11.1 Lipoid Kosmetik AG Corporation Information
12.11.2 Lipoid Kosmetik AG Business Overview
12.11.3 Lipoid Kosmetik AG Cosmetics Anti-inflammatory Ingredient Product Models, Descriptions and Specifications
12.11.4 Lipoid Kosmetik AG Cosmetics Anti-inflammatory Ingredient Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.11.5 Lipoid Kosmetik AG Recent Developments
12.12 Plamed Green Science Group
12.12.1 Plamed Green Science Group Corporation Information
12.12.2 Plamed Green Science Group Business Overview
12.12.3 Plamed Green Science Group Cosmetics Anti-inflammatory Ingredient Product Models, Descriptions and Specifications
12.12.4 Plamed Green Science Group Cosmetics Anti-inflammatory Ingredient Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.12.5 Plamed Green Science Group Recent Developments
12.13 Durae Corporation
12.13.1 Durae Corporation Corporation Information
12.13.2 Durae Corporation Business Overview
12.13.3 Durae Corporation Cosmetics Anti-inflammatory Ingredient Product Models, Descriptions and Specifications
12.13.4 Durae Corporation Cosmetics Anti-inflammatory Ingredient Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.13.5 Durae Corporation Recent Developments
12.14 Dermalab
12.14.1 Dermalab Corporation Information
12.14.2 Dermalab Business Overview
12.14.3 Dermalab Cosmetics Anti-inflammatory Ingredient Product Models, Descriptions and Specifications
12.14.4 Dermalab Cosmetics Anti-inflammatory Ingredient Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.14.5 Dermalab Recent Developments
12.15 The Garden of Naturalsolution
12.15.1 The Garden of Naturalsolution Corporation Information
12.15.2 The Garden of Naturalsolution Business Overview
12.15.3 The Garden of Naturalsolution Cosmetics Anti-inflammatory Ingredient Product Models, Descriptions and Specifications
12.15.4 The Garden of Naturalsolution Cosmetics Anti-inflammatory Ingredient Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.15.5 The Garden of Naturalsolution Recent Developments
12.16 Ashland
12.16.1 Ashland Corporation Information
12.16.2 Ashland Business Overview
12.16.3 Ashland Cosmetics Anti-inflammatory Ingredient Product Models, Descriptions and Specifications
12.16.4 Ashland Cosmetics Anti-inflammatory Ingredient Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.16.5 Ashland Recent Developments
12.17 Akema
12.17.1 Akema Corporation Information
12.17.2 Akema Business Overview
12.17.3 Akema Cosmetics Anti-inflammatory Ingredient Product Models, Descriptions and Specifications
12.17.4 Akema Cosmetics Anti-inflammatory Ingredient Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.17.5 Akema Recent Developments
12.18 Clariant
12.18.1 Clariant Corporation Information
12.18.2 Clariant Business Overview
12.18.3 Clariant Cosmetics Anti-inflammatory Ingredient Product Models, Descriptions and Specifications
12.18.4 Clariant Cosmetics Anti-inflammatory Ingredient Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.18.5 Clariant Recent Developments
12.19 Rita Corp
12.19.1 Rita Corp Corporation Information
12.19.2 Rita Corp Business Overview
12.19.3 Rita Corp Cosmetics Anti-inflammatory Ingredient Product Models, Descriptions and Specifications
12.19.4 Rita Corp Cosmetics Anti-inflammatory Ingredient Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.19.5 Rita Corp Recent Developments
12.20 ExperChem
12.20.1 ExperChem Corporation Information
12.20.2 ExperChem Business Overview
12.20.3 ExperChem Cosmetics Anti-inflammatory Ingredient Product Models, Descriptions and Specifications
12.20.4 ExperChem Cosmetics Anti-inflammatory Ingredient Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.20.5 ExperChem Recent Developments
12.21 Active Peptide Company
12.21.1 Active Peptide Company Corporation Information
12.21.2 Active Peptide Company Business Overview
12.21.3 Active Peptide Company Cosmetics Anti-inflammatory Ingredient Product Models, Descriptions and Specifications
12.21.4 Active Peptide Company Cosmetics Anti-inflammatory Ingredient Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.21.5 Active Peptide Company Recent Developments
12.22 Evolva
12.22.1 Evolva Corporation Information
12.22.2 Evolva Business Overview
12.22.3 Evolva Cosmetics Anti-inflammatory Ingredient Product Models, Descriptions and Specifications
12.22.4 Evolva Cosmetics Anti-inflammatory Ingredient Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.22.5 Evolva Recent Developments
12.23 Sabinsa
12.23.1 Sabinsa Corporation Information
12.23.2 Sabinsa Business Overview
12.23.3 Sabinsa Cosmetics Anti-inflammatory Ingredient Product Models, Descriptions and Specifications
12.23.4 Sabinsa Cosmetics Anti-inflammatory Ingredient Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.23.5 Sabinsa Recent Developments
12.24 InterHealth
12.24.1 InterHealth Corporation Information
12.24.2 InterHealth Business Overview
12.24.3 InterHealth Cosmetics Anti-inflammatory Ingredient Product Models, Descriptions and Specifications
12.24.4 InterHealth Cosmetics Anti-inflammatory Ingredient Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.24.5 InterHealth Recent Developments
12.25 Maypro
12.25.1 Maypro Corporation Information
12.25.2 Maypro Business Overview
12.25.3 Maypro Cosmetics Anti-inflammatory Ingredient Product Models, Descriptions and Specifications
12.25.4 Maypro Cosmetics Anti-inflammatory Ingredient Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.25.5 Maypro Recent Developments
12.26 Laurus Labs
12.26.1 Laurus Labs Corporation Information
12.26.2 Laurus Labs Business Overview
12.26.3 Laurus Labs Cosmetics Anti-inflammatory Ingredient Product Models, Descriptions and Specifications
12.26.4 Laurus Labs Cosmetics Anti-inflammatory Ingredient Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.26.5 Laurus Labs Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Cosmetics Anti-inflammatory Ingredient Industry Chain
13.2 Cosmetics Anti-inflammatory Ingredient Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Cosmetics Anti-inflammatory Ingredient Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Cosmetics Anti-inflammatory Ingredient Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Cosmetics Anti-inflammatory Ingredient Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Cosmetics Anti-inflammatory Ingredient Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
List of Tables
 Table 1. Global Cosmetics Anti-inflammatory Ingredient Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Cosmetics Anti-inflammatory Ingredient Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Cosmetics Anti-inflammatory Ingredient Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Cosmetics Anti-inflammatory Ingredient Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Cosmetics Anti-inflammatory Ingredient Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Cosmetics Anti-inflammatory Ingredient Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Kilotons)
 Table 7. Global Cosmetics Anti-inflammatory Ingredient Sales by Region (2020-2025) & (Kilotons)
 Table 8. Global Cosmetics Anti-inflammatory Ingredient Sales by Region (2026-2031) & (Kilotons)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Cosmetics Anti-inflammatory Ingredient Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Kilotons)
 Table 11. Global Cosmetics Anti-inflammatory Ingredient Production by Region (2020-2025) & (Kilotons)
 Table 12. Global Cosmetics Anti-inflammatory Ingredient Production by Region (2026-2031) & (Kilotons)
 Table 13. Global Cosmetics Anti-inflammatory Ingredient Sales by Manufacturers (2020-2025) & (Kilotons)
 Table 14. Global Cosmetics Anti-inflammatory Ingredient Sales Share by Manufacturers (2020-2025)
 Table 15. Global Cosmetics Anti-inflammatory Ingredient Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 16. Global Cosmetics Anti-inflammatory Ingredient Revenue Market Share by Manufacturers (2020-2025)
 Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 18. Global Cosmetics Anti-inflammatory Ingredient by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cosmetics Anti-inflammatory Ingredient as of 2024)
 Table 19. Global Cosmetics Anti-inflammatory Ingredient Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 20. Global Cosmetics Anti-inflammatory Ingredient Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
 Table 21. Key Manufacturers Cosmetics Anti-inflammatory Ingredient Manufacturing Base and Headquarters
 Table 22. Global Cosmetics Anti-inflammatory Ingredient Market Concentration Ratio (CR5 and HHI)
 Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 25. Global Cosmetics Anti-inflammatory Ingredient Sales by Type (2020-2025) & (Kilotons)
 Table 26. Global Cosmetics Anti-inflammatory Ingredient Sales by Type (2026-2031) & (Kilotons)
 Table 27. Global Cosmetics Anti-inflammatory Ingredient Revenue by Type (2020-2025) & (US$ Million)
 Table 28. Global Cosmetics Anti-inflammatory Ingredient Revenue by Type (2026-2031) & (US$ Million)
 Table 29. Global Cosmetics Anti-inflammatory Ingredient ASP by Type (2020-2031) & (US$/Ton)
 Table 30. Technical Specifications by Key Product Type
 Table 31. Global Cosmetics Anti-inflammatory Ingredient Sales by Application (2020-2025) & (Kilotons)
 Table 32. Global Cosmetics Anti-inflammatory Ingredient Sales by Application (2026-2031) & (Kilotons)
 Table 33. Cosmetics Anti-inflammatory Ingredient High-Growth Sectors Demand CAGR (2024-2031)
 Table 34. Global Cosmetics Anti-inflammatory Ingredient Revenue by Application (2020-2025) & (US$ Million)
 Table 35. Global Cosmetics Anti-inflammatory Ingredient Revenue by Application (2026-2031) & (US$ Million)
 Table 36. Global Cosmetics Anti-inflammatory Ingredient ASP by Application (2020-2031) & (US$/Ton)
 Table 37. Top Customers by Region
 Table 38. Top Customers by Application
 Table 39. North America Cosmetics Anti-inflammatory Ingredient Growth Accelerators and Market Barriers
 Table 40. North America Cosmetics Anti-inflammatory Ingredient Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 41. North America Cosmetics Anti-inflammatory Ingredient Sales (Kilotons) by Country (2020 VS 2024 VS 2031)
 Table 42. Europe Cosmetics Anti-inflammatory Ingredient Growth Accelerators and Market Barriers
 Table 43. Europe Cosmetics Anti-inflammatory Ingredient Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 44. Europe Cosmetics Anti-inflammatory Ingredient Sales (Kilotons) by Country (2020 VS 2024 VS 2031)
 Table 45. Asia-Pacific Cosmetics Anti-inflammatory Ingredient Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Asia-Pacific Cosmetics Anti-inflammatory Ingredient Sales (Kilotons) by Country (2020 VS 2024 VS 2031)
 Table 47. Asia-Pacific Cosmetics Anti-inflammatory Ingredient Growth Accelerators and Market Barriers
 Table 48. Southeast Asia Cosmetics Anti-inflammatory Ingredient Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 49. Central and South America Cosmetics Anti-inflammatory Ingredient Investment Opportunities and Key Challenges
 Table 50. Central and South America Cosmetics Anti-inflammatory Ingredient Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 51. Middle East and Africa Cosmetics Anti-inflammatory Ingredient Investment Opportunities and Key Challenges
 Table 52. Middle East and Africa Cosmetics Anti-inflammatory Ingredient Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 53. Lonza Corporation Information
 Table 54. Lonza Description and Major Businesses
 Table 55. Lonza Product Models, Descriptions and Specifications
 Table 56. Lonza Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 57. Lonza Sales Value Proportion by Product in 2024
 Table 58. Lonza Sales Value Proportion by Application in 2024
 Table 59. Lonza Sales Value Proportion by Geographic Area in 2024
 Table 60. Lonza Cosmetics Anti-inflammatory Ingredient SWOT Analysis
 Table 61. Lonza Recent Developments
 Table 62. Jubilant Life Sciences Corporation Information
 Table 63. Jubilant Life Sciences Description and Major Businesses
 Table 64. Jubilant Life Sciences Product Models, Descriptions and Specifications
 Table 65. Jubilant Life Sciences Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 66. Jubilant Life Sciences Sales Value Proportion by Product in 2024
 Table 67. Jubilant Life Sciences Sales Value Proportion by Application in 2024
 Table 68. Jubilant Life Sciences Sales Value Proportion by Geographic Area in 2024
 Table 69. Jubilant Life Sciences Cosmetics Anti-inflammatory Ingredient SWOT Analysis
 Table 70. Jubilant Life Sciences Recent Developments
 Table 71. Vertellus Corporation Information
 Table 72. Vertellus Description and Major Businesses
 Table 73. Vertellus Product Models, Descriptions and Specifications
 Table 74. Vertellus Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 75. Vertellus Sales Value Proportion by Product in 2024
 Table 76. Vertellus Sales Value Proportion by Application in 2024
 Table 77. Vertellus Sales Value Proportion by Geographic Area in 2024
 Table 78. Vertellus Cosmetics Anti-inflammatory Ingredient SWOT Analysis
 Table 79. Vertellus Recent Developments
 Table 80. Lasons India Corporation Information
 Table 81. Lasons India Description and Major Businesses
 Table 82. Lasons India Product Models, Descriptions and Specifications
 Table 83. Lasons India Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 84. Lasons India Sales Value Proportion by Product in 2024
 Table 85. Lasons India Sales Value Proportion by Application in 2024
 Table 86. Lasons India Sales Value Proportion by Geographic Area in 2024
 Table 87. Lasons India Cosmetics Anti-inflammatory Ingredient SWOT Analysis
 Table 88. Lasons India Recent Developments
 Table 89. DSM Corporation Information
 Table 90. DSM Description and Major Businesses
 Table 91. DSM Product Models, Descriptions and Specifications
 Table 92. DSM Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. DSM Sales Value Proportion by Product in 2024
 Table 94. DSM Sales Value Proportion by Application in 2024
 Table 95. DSM Sales Value Proportion by Geographic Area in 2024
 Table 96. DSM Cosmetics Anti-inflammatory Ingredient SWOT Analysis
 Table 97. DSM Recent Developments
 Table 98. BASF Corporation Information
 Table 99. BASF Description and Major Businesses
 Table 100. BASF Product Models, Descriptions and Specifications
 Table 101. BASF Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 102. BASF Recent Developments
 Table 103. Indena S.p.A. Corporation Information
 Table 104. Indena S.p.A. Description and Major Businesses
 Table 105. Indena S.p.A. Product Models, Descriptions and Specifications
 Table 106. Indena S.p.A. Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 107. Indena S.p.A. Recent Developments
 Table 108. Symrise Corporation Information
 Table 109. Symrise Description and Major Businesses
 Table 110. Symrise Product Models, Descriptions and Specifications
 Table 111. Symrise Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 112. Symrise Recent Developments
 Table 113. Croda Corporation Information
 Table 114. Croda Description and Major Businesses
 Table 115. Croda Product Models, Descriptions and Specifications
 Table 116. Croda Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 117. Croda Recent Developments
 Table 118. Seppic Corporation Information
 Table 119. Seppic Description and Major Businesses
 Table 120. Seppic Product Models, Descriptions and Specifications
 Table 121. Seppic Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 122. Seppic Recent Developments
 Table 123. Lipoid Kosmetik AG Corporation Information
 Table 124. Lipoid Kosmetik AG Description and Major Businesses
 Table 125. Lipoid Kosmetik AG Product Models, Descriptions and Specifications
 Table 126. Lipoid Kosmetik AG Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 127. Lipoid Kosmetik AG Recent Developments
 Table 128. Plamed Green Science Group Corporation Information
 Table 129. Plamed Green Science Group Description and Major Businesses
 Table 130. Plamed Green Science Group Product Models, Descriptions and Specifications
 Table 131. Plamed Green Science Group Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 132. Plamed Green Science Group Recent Developments
 Table 133. Durae Corporation Corporation Information
 Table 134. Durae Corporation Description and Major Businesses
 Table 135. Durae Corporation Product Models, Descriptions and Specifications
 Table 136. Durae Corporation Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 137. Durae Corporation Recent Developments
 Table 138. Dermalab Corporation Information
 Table 139. Dermalab Description and Major Businesses
 Table 140. Dermalab Product Models, Descriptions and Specifications
 Table 141. Dermalab Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 142. Dermalab Recent Developments
 Table 143. The Garden of Naturalsolution Corporation Information
 Table 144. The Garden of Naturalsolution Description and Major Businesses
 Table 145. The Garden of Naturalsolution Product Models, Descriptions and Specifications
 Table 146. The Garden of Naturalsolution Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 147. The Garden of Naturalsolution Recent Developments
 Table 148. Ashland Corporation Information
 Table 149. Ashland Description and Major Businesses
 Table 150. Ashland Product Models, Descriptions and Specifications
 Table 151. Ashland Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 152. Ashland Recent Developments
 Table 153. Akema Corporation Information
 Table 154. Akema Description and Major Businesses
 Table 155. Akema Product Models, Descriptions and Specifications
 Table 156. Akema Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 157. Akema Recent Developments
 Table 158. Clariant Corporation Information
 Table 159. Clariant Description and Major Businesses
 Table 160. Clariant Product Models, Descriptions and Specifications
 Table 161. Clariant Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 162. Clariant Recent Developments
 Table 163. Rita Corp Corporation Information
 Table 164. Rita Corp Description and Major Businesses
 Table 165. Rita Corp Product Models, Descriptions and Specifications
 Table 166. Rita Corp Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 167. Rita Corp Recent Developments
 Table 168. ExperChem Corporation Information
 Table 169. ExperChem Description and Major Businesses
 Table 170. ExperChem Product Models, Descriptions and Specifications
 Table 171. ExperChem Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 172. ExperChem Recent Developments
 Table 173. Active Peptide Company Corporation Information
 Table 174. Active Peptide Company Description and Major Businesses
 Table 175. Active Peptide Company Product Models, Descriptions and Specifications
 Table 176. Active Peptide Company Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 177. Active Peptide Company Recent Developments
 Table 178. Evolva Corporation Information
 Table 179. Evolva Description and Major Businesses
 Table 180. Evolva Product Models, Descriptions and Specifications
 Table 181. Evolva Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 182. Evolva Recent Developments
 Table 183. Sabinsa Corporation Information
 Table 184. Sabinsa Description and Major Businesses
 Table 185. Sabinsa Product Models, Descriptions and Specifications
 Table 186. Sabinsa Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 187. Sabinsa Recent Developments
 Table 188. InterHealth Corporation Information
 Table 189. InterHealth Description and Major Businesses
 Table 190. InterHealth Product Models, Descriptions and Specifications
 Table 191. InterHealth Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 192. InterHealth Recent Developments
 Table 193. Maypro Corporation Information
 Table 194. Maypro Description and Major Businesses
 Table 195. Maypro Product Models, Descriptions and Specifications
 Table 196. Maypro Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 197. Maypro Recent Developments
 Table 198. Laurus Labs Corporation Information
 Table 199. Laurus Labs Description and Major Businesses
 Table 200. Laurus Labs Product Models, Descriptions and Specifications
 Table 201. Laurus Labs Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 202. Laurus Labs Recent Developments
 Table 203. Key Raw Materials Distribution
 Table 204. Raw Materials Key Suppliers
 Table 205. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 206. Milestones in Production Technology Evolution
 Table 207. Distributors List
 Table 208. Market Trends and Market Evolution
 Table 209. Market Drivers and Opportunities
 Table 210. Market Challenges, Risks, and Restraints
 Table 211. Research Programs/Design for This Report
 Table 212. Key Data Information from Secondary Sources
 Table 213. Key Data Information from Primary Sources


List of Figures
 Figure 1. Cosmetics Anti-inflammatory Ingredient Product Picture
 Figure 2. Global Cosmetics Anti-inflammatory Ingredient Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Purslane Extract Product Picture
 Figure 4. Centella Asiatica Extract Product Picture
 Figure 5. Nicotinamide Product Picture
 Figure 6. Allantoin Product Picture
 Figure 7. Peptide Product Picture
 Figure 8. Bisabolol Product Picture
 Figure 9. Resveratrol Product Picture
 Figure 10. Others Product Picture
 Figure 11. Global Cosmetics Anti-inflammatory Ingredient Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 12. Facial Care
 Figure 13. Body Care
 Figure 14. Hand Care
 Figure 15. Foot Care
 Figure 16. Others
 Figure 17. Cosmetics Anti-inflammatory Ingredient Report Years Considered
 Figure 18. Global Cosmetics Anti-inflammatory Ingredient Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 19. Global Cosmetics Anti-inflammatory Ingredient Revenue (2020-2031) & (US$ Million)
 Figure 20. Global Cosmetics Anti-inflammatory Ingredient Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 21. Global Cosmetics Anti-inflammatory Ingredient Revenue Market Share by Region (2020-2031)
 Figure 22. Global Cosmetics Anti-inflammatory Ingredient Sales (2020-2031) & (Kilotons)
 Figure 23. Global Cosmetics Anti-inflammatory Ingredient Sales (CAGR) by Region (2020-2031) (Kilotons)
 Figure 24. Global Cosmetics Anti-inflammatory Ingredient Sales Market Share by Region (2020-2031)
 Figure 25. Global Cosmetics Anti-inflammatory Ingredient Capacity, Production and Utilization (2020-2031) & (Kilotons)
 Figure 26. Global Cosmetics Anti-inflammatory Ingredient Production Trend by Region (2020-2031) (Kilotons)
 Figure 27. Global Cosmetics Anti-inflammatory Ingredient Production Market Share by Region (2020-2031)
 Figure 28. Production Capacity Enablers & Constraints
 Figure 29. Cosmetics Anti-inflammatory Ingredient Production Growth Rate in North America (2020-2031) & (Kilotons)
 Figure 30. Cosmetics Anti-inflammatory Ingredient Production Growth Rate in Europe (2020-2031) & (Kilotons)
 Figure 31. Cosmetics Anti-inflammatory Ingredient Production Growth Rate in China (2020-2031) & (Kilotons)
 Figure 32. Cosmetics Anti-inflammatory Ingredient Production Growth Rate in Japan (2020-2031) & (Kilotons)
 Figure 33. Top 5 and Top 10 Manufacturers Cosmetics Anti-inflammatory Ingredient Sales Volume Market Share in 2024
 Figure 34. Global Cosmetics Anti-inflammatory Ingredient Revenue Market Share Ranking (2024)
 Figure 35. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 36. Purslane Extract Revenue Market Share by Manufacturer in 2024
 Figure 37. Centella Asiatica Extract Revenue Market Share by Manufacturer in 2024
 Figure 38. Nicotinamide Revenue Market Share by Manufacturer in 2024
 Figure 39. Allantoin Revenue Market Share by Manufacturer in 2024
 Figure 40. Peptide Revenue Market Share by Manufacturer in 2024
 Figure 41. Bisabolol Revenue Market Share by Manufacturer in 2024
 Figure 42. Resveratrol Revenue Market Share by Manufacturer in 2024
 Figure 43. Type Eight Revenue Market Share by Manufacturer in 2024
 Figure 44. Type Nine Revenue Market Share by Manufacturer in 2024
 Figure 45. Global Cosmetics Anti-inflammatory Ingredient Sales Market Share by Type (2020-2031)
 Figure 46. Global Cosmetics Anti-inflammatory Ingredient Revenue Market Share by Type (2020-2031)
 Figure 47. Global Cosmetics Anti-inflammatory Ingredient Sales Market Share by Application (2020-2031)
 Figure 48. Global Cosmetics Anti-inflammatory Ingredient Revenue Market Share by Application (2020-2031)
 Figure 49. North America Cosmetics Anti-inflammatory Ingredient Sales YoY (2020-2031) & (Kilotons)
 Figure 50. North America Cosmetics Anti-inflammatory Ingredient Revenue YoY (2020-2031) & (US$ Million)
 Figure 51. North America Top 5 Manufacturers Cosmetics Anti-inflammatory Ingredient Sales Revenue (US$ Million) in 2024
 Figure 52. North America Cosmetics Anti-inflammatory Ingredient Sales Volume (Kilotons) by Type (2020- 2031)
 Figure 53. North America Cosmetics Anti-inflammatory Ingredient Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 54. North America Cosmetics Anti-inflammatory Ingredient Sales Volume (Kilotons) by Application (2020-2031)
 Figure 55. North America Cosmetics Anti-inflammatory Ingredient Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 56. US Cosmetics Anti-inflammatory Ingredient Revenue (2020-2031) & (US$ Million)
 Figure 57. Canada Cosmetics Anti-inflammatory Ingredient Revenue (2020-2031) & (US$ Million)
 Figure 58. Mexico Cosmetics Anti-inflammatory Ingredient Revenue (2020-2031) & (US$ Million)
 Figure 59. Europe Cosmetics Anti-inflammatory Ingredient Sales YoY (2020-2031) & (Kilotons)
 Figure 60. Europe Cosmetics Anti-inflammatory Ingredient Revenue YoY (2020-2031) & (US$ Million)
 Figure 61. Europe Top 5 Manufacturers Cosmetics Anti-inflammatory Ingredient Sales Revenue (US$ Million) in 2024
 Figure 62. Europe Cosmetics Anti-inflammatory Ingredient Sales Volume (Kilotons) by Type (2020-2031)
 Figure 63. Europe Cosmetics Anti-inflammatory Ingredient Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 64. Europe Cosmetics Anti-inflammatory Ingredient Sales Volume (Kilotons) by Application (2020-2031)
 Figure 65. Europe Cosmetics Anti-inflammatory Ingredient Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 66. Germany Cosmetics Anti-inflammatory Ingredient Revenue (2020-2031) & (US$ Million)
 Figure 67. France Cosmetics Anti-inflammatory Ingredient Revenue (2020-2031) & (US$ Million)
 Figure 68. U.K. Cosmetics Anti-inflammatory Ingredient Revenue (2020-2031) & (US$ Million)
 Figure 69. Italy Cosmetics Anti-inflammatory Ingredient Revenue (2020-2031) & (US$ Million)
 Figure 70. Russia Cosmetics Anti-inflammatory Ingredient Revenue (2020-2031) & (US$ Million)
 Figure 71. Asia-Pacific Cosmetics Anti-inflammatory Ingredient Sales YoY (2020-2031) & (Kilotons)
 Figure 72. Asia-Pacific Cosmetics Anti-inflammatory Ingredient Revenue YoY (2020-2031) & (US$ Million)
 Figure 73. Asia-Pacific Top 8 Manufacturers Cosmetics Anti-inflammatory Ingredient Sales Revenue (US$ Million) in 2024
 Figure 74. Asia-Pacific Cosmetics Anti-inflammatory Ingredient Sales Volume (Kilotons) by Type (2020- 2031)
 Figure 75. Asia-Pacific Cosmetics Anti-inflammatory Ingredient Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 76. Asia-Pacific Cosmetics Anti-inflammatory Ingredient Sales Volume (Kilotons) by Application (2020-2031)
 Figure 77. Asia-Pacific Cosmetics Anti-inflammatory Ingredient Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 78. Indonesia Cosmetics Anti-inflammatory Ingredient Revenue (2020-2031) & (US$ Million)
 Figure 79. Japan Cosmetics Anti-inflammatory Ingredient Revenue (2020-2031) & (US$ Million)
 Figure 80. South Korea Cosmetics Anti-inflammatory Ingredient Revenue (2020-2031) & (US$ Million)
 Figure 81. China Taiwan Cosmetics Anti-inflammatory Ingredient Revenue (2020-2031) & (US$ Million)
 Figure 82. India Cosmetics Anti-inflammatory Ingredient Revenue (2020-2031) & (US$ Million)
 Figure 83. Central and South America Cosmetics Anti-inflammatory Ingredient Sales YoY (2020-2031) & (Kilotons)
 Figure 84. Central and South America Cosmetics Anti-inflammatory Ingredient Revenue YoY (2020-2031) & (US$ Million)
 Figure 85. Central and South America Top 5 Manufacturers Cosmetics Anti-inflammatory Ingredient Sales Revenue (US$ Million) in 2024
 Figure 86. Central and South America Cosmetics Anti-inflammatory Ingredient Sales Volume (Kilotons) by Type (2021-2031)
 Figure 87. Central and South America Cosmetics Anti-inflammatory Ingredient Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 88. Central and South America Cosmetics Anti-inflammatory Ingredient Sales Volume (Kilotons) by Application (2020-2031)
 Figure 89. Central and South America Cosmetics Anti-inflammatory Ingredient Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 90. Brazil Cosmetics Anti-inflammatory Ingredient Revenue (2020-2025) & (US$ Million)
 Figure 91. Argentina Cosmetics Anti-inflammatory Ingredient Revenue (2020-2025) & (US$ Million)
 Figure 92. Middle East, and Africa Cosmetics Anti-inflammatory Ingredient Sales YoY (2020-2031) & (Kilotons)
 Figure 93. Middle East and Africa Cosmetics Anti-inflammatory Ingredient Revenue YoY (2020-2031) & (US$ Million)
 Figure 94. Middle East and Africa Top 5 Manufacturers Cosmetics Anti-inflammatory Ingredient Sales Revenue (US$ Million) in 2024
 Figure 95. Middle East and Africa Cosmetics Anti-inflammatory Ingredient Sales Volume (Kilotons) by Type (2021-2031)
 Figure 96. South America Cosmetics Anti-inflammatory Ingredient Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 97. Middle East and Africa Cosmetics Anti-inflammatory Ingredient Sales Volume (Kilotons) by Application (2020-2031)
 Figure 98. Middle East and Africa Cosmetics Anti-inflammatory Ingredient Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 99. GCC Countries Cosmetics Anti-inflammatory Ingredient Revenue (2020-2025) & (US$ Million)
 Figure 100. Turkey Cosmetics Anti-inflammatory Ingredient Revenue (2020-2025) & (US$ Million)
 Figure 101. Egypt Cosmetics Anti-inflammatory Ingredient Revenue (2020-2025) & (US$ Million)
 Figure 102. South Africa Cosmetics Anti-inflammatory Ingredient Revenue (2020-2025) & (US$ Million)
 Figure 103. Cosmetics Anti-inflammatory Ingredient Industry Chain Mapping
 Figure 104. Regional Cosmetics Anti-inflammatory Ingredient Manufacturing Base Distribution (%)
 Figure 105. Cosmetics Anti-inflammatory Ingredient Production Process
 Figure 106. Regional Cosmetics Anti-inflammatory Ingredient Production Cost Structure
 Figure 107. Channels of Distribution (Direct Vs Distribution)
 Figure 108. Bottom-up and Top-down Approaches for This Report
 Figure 109. Data Triangulation
 Figure 110. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String